The Los Angeles Post
U.S. World Business Lifestyle
Today: March 27, 2025
Today: March 27, 2025

Health insurer Centene eases investor fears with better-than-expected profit

A sign for Fidelis Care, part of the Centene Corporation, is seen in Queens, New York
October 25, 2024

By Sriparna Roy and Unnamalai L

(Reuters) -Centene beat Wall Street estimates for third-quarter earnings on strength in its commercial health insurance plans and maintained its annual profit forecast, easing investor fears after dour targets from rivals last week.

Shares of the health insurer jumped nearly 12% to $68.92 in early trading on Friday. They fell 16% in the last week after rivals Elevance and UnitedHealth warned of high costs in government-backed insurance plans.

Costs for insurers providing Medicaid plans have been elevated after a federal policy that required insurers to keep low-income Americans enrolled in health plans during the COVID-19 pandemic ended last year, and left the insurers with more sick patients.

The quarter was "much better than expected", said Baird analyst Michael Ha, adding that it was a "surprise" after peers reported "unprecedented levels" of Medicaid pressure last week.

Centene said it expects costs to ease next year as the 'mismatch' between what states pay insurers to cover Medicaid members and the amount the insurers spend on care for the members minimizes.

It is "not a matter of if, but when, we get back to equilibrium", CFO Drew Asher said in a call with analysts.

For the full year, Centene expects a medical loss ratio โ€” the percentage of premiums spent on medical care โ€” of 88.3% to 88.5%, compared with analysts' average estimate of 87.93%, according to data compiled by LSEG.

It reported a ratio of 89.2% for the quarter ended Sept. 30. Analysts had expected 88.03%.

Despite higher costs, the company maintained its annual profit forecast of greater than $6.80 per share, compared with analysts' expectation of $6.73.

Investors had been preparing for a potential cut to Centene forecast, said Stephens analyst Scott Fidel.

Centene reported quarterly profit of $1.62 per share, above analysts' average estimate of $1.33.

(Reporting by Amina Niasse in New York City, Sriparna Roy and Unnamalai L in Bengaluru; Editing by Shilpi Majumdar and Shinjini Ganguli)

Related Articles

UnitedHealth forecasts 2025 profit largely in line with estimates Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs Novo, Lilly shares rise as Biden proposes obesity care coverage Biden proposes expanded Medicare, Medicaid coverage of obesity drugs
Share This

Popular

Business|Political|Technology|US

US robotics companies push for national strategy, including a central office, to compete with China

US robotics companies push for national strategy, including a central office, to compete with China
Business|Technology|US

Judge allows newspaper copyright lawsuit against OpenAI to proceed

Judge allows newspaper copyright lawsuit against OpenAI to proceed
Business|Economy|Finance|Political|Stock Markets|US

Trump places 25% tariff on imported autos, expecting to raise $100 billion in tax revenues

Trump places 25% tariff on imported autos, expecting to raise $100 billion in tax revenues
Americas|Business|Economy|Election|Political|US

Canadian Prime Minister Carney calls Trump's auto tariffs a 'direct attack' on his country

Canadian Prime Minister Carney calls Trump's auto tariffs a 'direct attack' on his country

Health

Health|US

Kansas measles cases double to 23 and new Ohio outbreak sickens 10

Kansas measles cases double to 23 and new Ohio outbreak sickens 10
Health|Political|US

Trump administration says it will pull back billions in COVID funding from local health departments

Trump administration says it will pull back billions in COVID funding from local health departments
Health|Lifestyle

Hereโ€™s why you keep waking up to pee in the middle of the night

Hereโ€™s why you keep waking up to pee in the middle of the night
Health|Sports

How a cancer diagnosis changed tennis player Gaby Dabrowski's perspective

How a cancer diagnosis changed tennis player Gaby Dabrowski's perspective